Fig. 10

Physical attributes of different glycans at NK cell surfaces affecting the immunological functions to augmented cancer cell killing. a Glycoengineering approach for cancer cell membrane modification to prevent killing from NK cell, (b) glycomodulation of NK cells via CD22 specific ligands, (c) surface modulation of NK cells by Siglic–7, and (d) metalbolic glycoengineering of NK cells for antibody-mediated targeting cancer cell killing